Join
Live feed
·
INSIDERFilingvia Quantisnow
Harvard Bioscience Inc. logo

Director Eade Katherine A. was granted 16,556 shares, increasing direct ownership by 39% to 58,669 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
HBIO· Harvard Bioscience Inc.
Industrials
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HBIO (Harvard Bioscience Inc.) and more on Quantisnow.